|
RAB11FIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.405600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.692200E-01 |
| Normal-vs-Stage2 |
4.698400E-01 |
| Normal-vs-Stage3 |
8.315900E-02 |
| Normal-vs-Stage4 |
1.019600E-01 |
| Stage1-vs-Stage2 |
8.054400E-01 |
| Stage1-vs-Stage3 |
1.912040E-01 |
| Stage1-vs-Stage4 |
3.910200E-01 |
| Stage2-vs-Stage3 |
4.177000E-01 |
| Stage2-vs-Stage4 |
4.456000E-01 |
| Stage3-vs-Stage4 |
9.918600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.688200E-01 |
| Normal-vs-AfricanAmerican |
4.292000E-01 |
| Normal-vs-Asian |
2.555300E-04 |
| Caucasian-vs-AfricanAmerican |
9.734400E-01 |
| Caucasian-vs-Asian |
1.884220E-01 |
| AfricanAmerican-vs-Asian |
1.192410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.134000E-02 |
| Normal-vs-Female |
3.803800E-01 |
| Male-vs-Female |
3.762300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.133700E-02 |
| Normal-vs-Extreme_Weight |
1.150170E-01 |
| Normal-vs-Obese |
9.962400E-01 |
| Normal-vs-Extreme_Obese |
3.598800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.938400E-01 |
| Normal_Weight-vs-Obese |
1.396200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.261200E-01 |
| Extreme_Weight-vs-Obese |
2.297800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.933400E-01 |
| Obese-vs-Extreme_Obese |
4.437600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.999000E-03 |
| Normal-vs-Age(41-60Yrs) |
7.353200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.166300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.385600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.862400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.856560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.603600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.847900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.357980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.165800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.214600E-01 |
| Normal-VS-Type2 PRCC |
1.564150E-03 |
| Normal-VS-KIRP CIMP |
8.143800E-03 |
| Normal-VS-Unclassified PRCC |
5.527200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.459500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.627900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.054400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.821200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.016370E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.400100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.379960E-03 |
| Normal-vs-N1 |
2.422800E-03 |
| Normal-vs-N2 |
1.996170E-01 |
| N0-vs-N1 |
8.677200E-01 |
| N0-vs-N2 |
6.367400E-01 |
| N1-vs-N2 |
6.330000E-01 |
|
|
